The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world

Kishor M. Wasan; Sheila J. Thornton; Ian Bell; Rebecca E. Goulding; Michael Gretes; Andrew P. Gray; Robert E.W. Hancock; Barbara Campbell

doi:10.1002/jps.21495

The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world

Kishor M. Wasan
, Sheila J. Thornton
, Ian Bell
, Rebecca E. Goulding
, Michael Gretes
, Andrew P. Gray
, Robert E.W. Hancock
, Barbara Campbell

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

The University of British Columbia (UBC) became the first university in Canada to develop a strategy for enhancing global access to its technologies. UBC's University-Industry Liaison Office, in collaboration with the UBC chapter of Universities Allied for Essential Medicines (UAEM), established a mandate and developed principles that provide the developing world with access to UBC technologies. This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies.

Original language	English
Pages (from-to)	791-794
Number of pages	4
Journal	Journal of Pharmaceutical Sciences
Volume	98
Issue number	3
DOIs	https://doi.org/10.1002/jps.21495
Publication status	Published or Issued - Mar 2009
Externally published	Yes

Keywords

Absorption potential
Antiinfectives
Formulation
Nanotechnology
Vaccine delivery

ASJC Scopus subject areas

Pharmaceutical Science

Access to Document

10.1002/jps.21495

Cite this

@article{13756d62ec5040028e26238c064e6d1b,

title = "The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world",

abstract = "The University of British Columbia (UBC) became the first university in Canada to develop a strategy for enhancing global access to its technologies. UBC's University-Industry Liaison Office, in collaboration with the UBC chapter of Universities Allied for Essential Medicines (UAEM), established a mandate and developed principles that provide the developing world with access to UBC technologies. This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies.",

keywords = "Absorption potential, Antiinfectives, Formulation, Nanotechnology, Vaccine delivery",

author = "Wasan, \{Kishor M.\} and Thornton, \{Sheila J.\} and Ian Bell and Goulding, \{Rebecca E.\} and Michael Gretes and Gray, \{Andrew P.\} and Hancock, \{Robert E.W.\} and Barbara Campbell",

year = "2009",

month = mar,

doi = "10.1002/jps.21495",

language = "English",

volume = "98",

pages = "791--794",

journal = "Journal of Pharmaceutical Sciences",

issn = "0022-3549",

publisher = "Elsevier B.V.",

number = "3",

}

TY - JOUR

T1 - The global access initiative at the University of British Columbia (UBC)

T2 - Availability of UBC discoveries and technologies to the developing world

AU - Wasan, Kishor M.

AU - Thornton, Sheila J.

AU - Bell, Ian

AU - Goulding, Rebecca E.

AU - Gretes, Michael

AU - Gray, Andrew P.

AU - Hancock, Robert E.W.

AU - Campbell, Barbara

PY - 2009/3

Y1 - 2009/3

N2 - The University of British Columbia (UBC) became the first university in Canada to develop a strategy for enhancing global access to its technologies. UBC's University-Industry Liaison Office, in collaboration with the UBC chapter of Universities Allied for Essential Medicines (UAEM), established a mandate and developed principles that provide the developing world with access to UBC technologies. This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies.

AB - The University of British Columbia (UBC) became the first university in Canada to develop a strategy for enhancing global access to its technologies. UBC's University-Industry Liaison Office, in collaboration with the UBC chapter of Universities Allied for Essential Medicines (UAEM), established a mandate and developed principles that provide the developing world with access to UBC technologies. This commentary will discuss these principles and provide examples of where they have been applied to several UBC technologies.

KW - Absorption potential

KW - Antiinfectives

KW - Formulation

KW - Nanotechnology

KW - Vaccine delivery

UR - https://www.scopus.com/pages/publications/62849094149

U2 - 10.1002/jps.21495

DO - 10.1002/jps.21495

M3 - Article

C2 - 18688820

AN - SCOPUS:62849094149

SN - 0022-3549

VL - 98

SP - 791

EP - 794

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

IS - 3

ER -

The global access initiative at the University of British Columbia (UBC): Availability of UBC discoveries and technologies to the developing world

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this